ENTITY
ImmuneOnco Biopharmaceuticals (Shanghai)

ImmuneOnco Biopharmaceuticals (Shanghai) (IOB HK)

8
Analysis
Health CareChina

Refresh
06 Aug 2024 07:45Broker

ImmuneOnco (1541 HK) - Achieved Significant Overseas Licensing Partnership

Successful overseas licensing of PD-L1xVEGF bsAb and anti-CTLA4 mAb. ImmuneOnco reached an agreement with SynBioTx (a wholly - owned subsidiary of...

Logo
166 Views
Share
14 Jan 2024 09:34

China Healthcare Weekly (Jan.12) - Mainstream R&D Trend, Innovent, BeiGene, Sirnaomics, ImmuneOnco

If we look at mainstream R&D trend, the choices made by companies like Innovent/BeiGene are reasonable. Investment value of Sirnaomics is low....

Logo
472 Views
Share
bullishUBTech Robotics
18 Feb 2024 11:00

HSCI Index Rebalance: 25 Adds, 29 Deletes & Changes to Southbound Stock Connect

There are 25 adds and 29 deletes for the HSCI in March. 21 stocks will be added to Stock Connect while 27 will be deleted. Positions via the...

Logo
702 Views
Share
bullishShriram Finance
07 Jan 2024 05:10

Index Rebalance & ETF Flow Recap: HSCEI, HSCI, KRX New Deal, NIFTY50, NEXT50, CNXBANK

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
794 Views
Share
bullishWuXi XDC Cayman
03 Jan 2024 05:00

HSCI Index Rebalance Preview and Stock Connect: Potential Changes in March

There could be nearly 58 adds/deletes for the HSCI in September. That will trigger changes to the Southbound Stock Connect list and increase flows...

Logo
962 Views
Share
x